FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297785693> ?p ?o ?g. }

• W4297785693 endingPage "1997" @default.
• W4297785693 startingPage "1988" @default.
• W4297785693 abstract "B-cell activating factor (BAFF) is implicated in SLE pathogenesis. Blocking BAFF signalling has contributed to reducing glucocorticoid dosage and preventing organ damage. However, clinical characteristics of patients who may benefit from this therapy are not yet fully elucidated. Therefore, we identified patients with high BAFF-bioactivity to investigate their clinical characteristics and BAFF-producing cells.We established the reporter cell for BAFF and investigated the clinical characteristics of SLE patients with high BAFF-bioactivity. We identified BAFF-expressing kidney cells using publicly available scRNA-seq data and immunohistological analysis. SLE patients were stratified based on the bioactivity of BAFF and type-I IFN (IFN-I) to identify associated characteristic clinical manifestations.SLE patients, especially patients with LN, had significantly higher serum BAFF-bioactivity than healthy controls (HC) and non-LN patients. Additionally, single-cell-RNA-seq data and immunohistological analysis of kidney samples from LN patients revealed that BAFF is expressed in glomerular macrophages and mesangial cells. Notably, BAFF bioactivity was elevated in the urine of LN patients compared with that of non-LN patients, while no IFN-I bioactivity was detected in the urine. Furthermore, SLE stratification based on bioactivities of serum BAFF and IFN-I revealed the clinical characteristics of patients: high BAFF represented patients with LN and high IFN-I represented patients with blood and skin manifestations.Monitoring urinary BAFF-bioactivity may be valuable in diagnosing LN. Furthermore, stratification based on serum BAFF and IFN-I bioactivities may allow the identification of appropriate patients for biologics targeting BAFF and IFN-I." @default.
• W4297785693 created "2022-10-01" @default.
• W4297785693 creator A5012343015 @default.
• W4297785693 creator A5013012246 @default.
• W4297785693 creator A5021042550 @default.
• W4297785693 creator A5026533624 @default.
• W4297785693 creator A5026633755 @default.
• W4297785693 creator A5035346649 @default.
• W4297785693 creator A5037133689 @default.
• W4297785693 creator A5037662951 @default.
• W4297785693 creator A5041682962 @default.
• W4297785693 creator A5052877085 @default.
• W4297785693 creator A5055433817 @default.
• W4297785693 creator A5060949610 @default.
• W4297785693 creator A5070214016 @default.
• W4297785693 creator A5072529916 @default.
• W4297785693 creator A5076618039 @default.
• W4297785693 creator A5081617768 @default.
• W4297785693 creator A5083709357 @default.
• W4297785693 creator A5089114137 @default.
• W4297785693 date "2022-09-12" @default.
• W4297785693 modified "2023-10-17" @default.
• W4297785693 title "SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis" @default.
• W4297785693 cites W1516874144 @default.
• W4297785693 cites W1518008196 @default.
• W4297785693 cites W1596190107 @default.
• W4297785693 cites W1920115643 @default.
• W4297785693 cites W1978302597 @default.
• W4297785693 cites W1997105134 @default.
• W4297785693 cites W2014956545 @default.
• W4297785693 cites W2022900996 @default.
• W4297785693 cites W2031097604 @default.
• W4297785693 cites W2052079772 @default.
• W4297785693 cites W2059504760 @default.
• W4297785693 cites W2070527591 @default.
• W4297785693 cites W2108905161 @default.
• W4297785693 cites W2111940985 @default.
• W4297785693 cites W2120679720 @default.
• W4297785693 cites W2129540623 @default.
• W4297785693 cites W2132773720 @default.
• W4297785693 cites W2140296331 @default.
• W4297785693 cites W2141455950 @default.
• W4297785693 cites W2142793548 @default.
• W4297785693 cites W2156049613 @default.
• W4297785693 cites W2159860161 @default.
• W4297785693 cites W2321809676 @default.
• W4297785693 cites W2322139300 @default.
• W4297785693 cites W2486559230 @default.
• W4297785693 cites W2556359407 @default.
• W4297785693 cites W2609734256 @default.
• W4297785693 cites W2625419804 @default.
• W4297785693 cites W2626676919 @default.
• W4297785693 cites W2782542157 @default.
• W4297785693 cites W2783077734 @default.
• W4297785693 cites W2805930941 @default.
• W4297785693 cites W2809821375 @default.
• W4297785693 cites W2891788869 @default.
• W4297785693 cites W2897114391 @default.
• W4297785693 cites W2922125755 @default.
• W4297785693 cites W2940629192 @default.
• W4297785693 cites W2944872709 @default.
• W4297785693 cites W2949177718 @default.
• W4297785693 cites W2949631571 @default.
• W4297785693 cites W2995521654 @default.
• W4297785693 cites W3006274804 @default.
• W4297785693 cites W3012553260 @default.
• W4297785693 cites W3022625162 @default.
• W4297785693 cites W3085025551 @default.
• W4297785693 cites W3086555810 @default.
• W4297785693 cites W3092453598 @default.
• W4297785693 cites W3095797857 @default.
• W4297785693 cites W3111529194 @default.
• W4297785693 doi "https://doi.org/10.1093/rheumatology/keac528" @default.
• W4297785693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36094336" @default.
• W4297785693 hasPublicationYear "2022" @default.
• W4297785693 type Work @default.
• W4297785693 citedByCount "7" @default.
• W4297785693 countsByYear W42977856932023 @default.
• W4297785693 crossrefType "journal-article" @default.
• W4297785693 hasAuthorship W4297785693A5012343015 @default.
• W4297785693 hasAuthorship W4297785693A5013012246 @default.
• W4297785693 hasAuthorship W4297785693A5021042550 @default.
• W4297785693 hasAuthorship W4297785693A5026533624 @default.
• W4297785693 hasAuthorship W4297785693A5026633755 @default.
• W4297785693 hasAuthorship W4297785693A5035346649 @default.
• W4297785693 hasAuthorship W4297785693A5037133689 @default.
• W4297785693 hasAuthorship W4297785693A5037662951 @default.
• W4297785693 hasAuthorship W4297785693A5041682962 @default.
• W4297785693 hasAuthorship W4297785693A5052877085 @default.
• W4297785693 hasAuthorship W4297785693A5055433817 @default.
• W4297785693 hasAuthorship W4297785693A5060949610 @default.
• W4297785693 hasAuthorship W4297785693A5070214016 @default.
• W4297785693 hasAuthorship W4297785693A5072529916 @default.
• W4297785693 hasAuthorship W4297785693A5076618039 @default.
• W4297785693 hasAuthorship W4297785693A5081617768 @default.
• W4297785693 hasAuthorship W4297785693A5083709357 @default.
• W4297785693 hasAuthorship W4297785693A5089114137 @default.
• W4297785693 hasBestOaLocation W42977856932 @default.

• next